Equine infectious anemia virus Gag p9 function in early steps of virus infection and provirus production.
We have previously reported that serial truncation of the Gag p9 protein of equine infectious anemia virus (EIAV) revealed a progressive loss in replication phenotypes in transfected cells, such that a proviral mutant (E32) expressing the N-terminal 31 amino acids of p9 produced infectious virus particles similarly to parental provirus, while a proviral mutant (K30) with two fewer amino acids produced replication-defective virus particles, despite containing apparently normal levels of processed Gag and Pol proteins (C. Chen, F. Li, and R. C. Montelaro, J. Virol. 75:9762-9760, 2001). Based on these observations, we sought in the current study to identify the precise defect in K30 virion infection of permissive equine dermal (ED) cells. The results of these experiments clearly demonstrated that K30 virions entered target ED cells and produced early (minus-strand strong-stop) and late (Gag) viral DNA products as efficiently as did the replication-competent E32 mutant and parental EIAV(UK) viruses. However, in contrast to the replication-competent E32 mutant and parental viruses, infection with K30 mutant virus failed to produce detectable two-long-terminal-repeat DNA circles, stable integrated provirus, virus-specific Gag mRNA expression, or intracellular viral protein expression. Taken together, these data demonstrate that the K30 mutant is defective in the ability to produce sufficient nuclear viral DNA to establish a productive infection in ED cells. Thus, these observations indicate for the first time that the EIAV Gag p9 protein performs a critical role in viral DNA production and processing to provirus during EIAV infection, in addition to its previously defined role in viral budding mediated by the p9 L domain.
Jin
Sha
S
Department of Molecular Genetics and Biochemistry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Chen
Chaoping
C
Montelaro
Ronald C
RC
D021581:Active Transport, Cell Nucleus; D000818:Animals; D019556:COS Cells; D004279:DNA, Viral / Q000096:biosynthesis; D015683:Gene Products, gag / Q000502:physiology*; D006736:Horses; D004860:Infectious Anemia Virus, Equine / Q000502:physiology*; D011533:Proviruses / Q000502:physiology*; D014158:Transcription, Genetic; D014764:Viral Proteins / Q000096:biosynthesis; D016662:Virus Integration; D014779:Virus Replication
D004279:DNA, Viral; D015683:Gene Products, gag; D014764:Viral Proteins